NetworkNewsBreaks – Predictive Oncology Inc. (NA
Post# of 280
Predictive Oncology (NASDAQ: POAI), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, today announced the unanimous appointment of Pam Prior, CPA, to its Board of Directors. According to the update, Prior is the founder and CEO of Priorities Group, Inc., a provider of CFO services to small and mid-sized businesses, and has approximately 35 years of previous experience in accounting, predominantly in management as a chief financial officer and controller. “Predictive Oncology is very fortunate to announce that Pam Prior is joining our Board of Directors,” Predictive Oncology CEO Dr. Carl Schwartz said in the news release. “Pam possesses a strong financial background, including in the genomic and health industry fields. She will chair our audit committee, providing new insights and guidance to our Board and the financial departments of the Company. I greatly anticipate working with Pam and experiencing the successful approach she has honed over the years.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer